Needham reiterated a Buy rating on Autolus Therapeutics while acknowledging the potential of AI stocks.
2 reports, 1 independent
Updated Aug 24
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Needham reiterated a Buy rating on Autolus Therapeutics while acknowledging the potential of AI stocks.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Autolus Therapeutics
company in London, United Kingdom
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider MonkeyNeedham Keeps Buy Rating on Autolus (AUTL) with a $10 Target Autolus Therapeutics plc (NASDAQ:AUTL) is one of the 10 Best Penny Stocks to Buy for the Next 5 Years. On August 12, Needham reiterated a
- Unknown outlet